Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Rhythm Pharmaceuticals, Inc."
Count: 23
Selected: 0
| NCT ID | Title |
|---|
| NCT04966741 | Setmelanotide in Pediatric Rare Genetic Diseases of Obesity | ||
| NCT05194124 | A Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the Melanocortin-4 Receptor Pathway | ||
| NCT05183802 | An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS) | ||
| NCT03262610 | Setmelanotide in a Single Patient With Partial Lipodystrophy | ||
| NCT04725240 | Open-Label Study of Setmelanotide in Hypothalamic Obesity | ||
| NCT05093634 | EMANATE: Phase 3 Study of Setmelanotide in Patients With POMC, PCSK1, LEPR, SRC1, SH2B1, or PCSK1 N221D Genetic Variants | ||
| NCT05046132 | Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Subjects | ||
| NCT03651765 | Long Term Extension Trial of Setmelanotide | ||
| NCT03746522 | Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity | ||
| NCT03013543 | Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity | ||
| NCT04963231 | DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway | ||
| NCT04348175 | A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment | ||
| NCT03621007 | An Observational,Prospective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function Mutations in the POMC, PCSK1 or LEPR Genes | ||
| NCT03479437 | The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry | ||
| NCT03287960 | Setmelanotide for the Treatment of LEPR Deficiency Obesity | ||
| NCT02896192 | Setmelanotide for the Treatment of Early-Onset POMC Deficiency Obesity | ||
| NCT02849977 | Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers | ||
| NCT02311673 | Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome | ||
| NCT01867437 | Effects of RM-493 on Energy Expenditure in Obese Individuals | ||
| NCT02041195 | Phase 1b/2a Study to Evaluate Safety and Efficacy of RM-493 in Obese Patients | ||
| NCT02431442 | Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers | ||
| NCT01749137 | Phase 2 Study to Evaluate Safety and Efficacy of Rm-493 in Obese Patients | ||
| NCT01849705 | Melanocortin 4 Receptor Mutations and Obesity-associated Diseases |
